Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer.

Abstract:

:Twenty-seven patients with advanced cancer were entered in a phase I study of bolus i.v. 5-fluorouracil at a dose of 370 mg/m2/day for 5 days combined with a continuous i.v. infusion of (6S)-folinic acid for 5.5 days, starting 24 h in advance of the first 5-fluorouracil dose. The dose of (6S)-folinic acid was escalated in cohorts of patients from 250 mg/m2/day to a maximum of 1000 mg/m2/day. The pharmacokinetics of (6S)-folinic acid were studied in the 3 patients given 250 mg/m2/day and in 6 patients given 1000 mg/m2/day. The mean steady-state plasma concentrations of (6S)-folinic acid and its principal metabolite (6S)-5-methyltetrahydrofolate at the 250 mg/m2/day dose were 2.7 and 5.1 microM, respectively. Both concentrations were comparable to the concentrations produced when (6S)-folinic acid was administered as half of a (6R,S)-folinic acid mixture (E. M. Newman et al., Cancer Res., 49:5755-5760, 1989). At the 1000 mg/m2/day dose of (6S)-folinic acid, the concentration of (6S)-folinic acid was 15.3 microM, more than the 4-fold increase predicted by linear pharmacokinetics, while the concentration of (6S)-5-methyltetrahydrofolate was only 16.5 microM. The change in the ratio of the parent compound to its metabolite was accounted for by a decrease in the nonrenal clearance of (6S)-folinic acid, probably indicating saturation of its metabolism. The toxicities observed in this phase I trial, including stomatitis, diarrhea, neutropenia, and anemia, did not differ in nature or severity from those produced by 5-fluorouracil and (6R,S)-folinic acid when administered on the same schedule. Finally, the degree of toxicity did not appear to depend on the dose of (6S)-folinic acid over the range of doses tested.

journal_name

Cancer Res

journal_title

Cancer research

authors

Newman EM,Akman SA,Harrison JS,Leong LA,Margolin KA,Morgan RJ,Raschko JW,Somlo G,Ahn CW,Doroshow JH

subject

Has Abstract

pub_date

1992-05-01 00:00:00

pages

2408-12

issue

9

eissn

0008-5472

issn

1538-7445

journal_volume

52

pub_type

临床试验,杂志文章
  • Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network.

    abstract::Inactivation of the tumor suppressor p53 through somatic mutations, observed in 50% of human cancers, is one of the leading causes of tumorigenesis. Clinical and experimental evidence also reveals that p53 mutations sometimes occur in tumor-associated fibroblasts, which correlate with an increased rate of metastases a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-3810

    authors: Guo G,Marrero L,Rodriguez P,Del Valle L,Ochoa A,Cui Y

    更新日期:2013-03-15 00:00:00

  • Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.

    abstract::Spontaneous tumorigenesis was evaluated in male p53-knockout (p53-/-) mice treated with dehydroepiandrosterone (DHEA), quercetin, d-limonene, or all-trans retinoic acid to determine whether tumor development in these mice can be modulated by cancer-chemopreventive agents. DHEA-treated mice experienced a delay in tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hursting SD,Perkins SN,Haines DC,Ward JM,Phang JM

    更新日期:1995-09-15 00:00:00

  • Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.

    abstract::The expression of the mucin-bound sialyl-Lewisx epitope is increased in the tissue of most colorectal carcinomas and in the sera of about 30% of tumor patients. In colon cancer, a portion of the sialyl-Lex groups detectable with the monoclonal antibody AM-3 is located on MUC1 (C. Hanski et al., Cancer Res., 53: 4082-4...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hanski C,Hanski ML,Zimmer T,Ogorek D,Devine P,Riecken EO

    更新日期:1995-02-15 00:00:00

  • PDT: What's Past Is Prologue.

    abstract::Despite descriptions of light-mediated therapy in ancient texts and the discovery of photodynamic therapy (PDT) in the early 1900s, the landmark article in 1978 in Cancer Research by Dougherty and his colleagues at the Roswell Park Cancer Institute remains rightly viewed as the starting point for clinical PDT in moder...

    journal_title:Cancer research

    pub_type: 社论,历史文章

    doi:10.1158/0008-5472.CAN-16-0927

    authors: Cengel KA,Simone CB 2nd,Glatstein E

    更新日期:2016-05-01 00:00:00

  • HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism.

    abstract::Cytochrome P450 aromatase (aromatase), a product of the CYP19 gene, catalyzes the synthesis of estrogens from androgens. Given the significance of estrogen synthesis in hormone-dependent breast carcinogenesis, it is important to elucidate the mechanisms that regulate CYP19 expression. The main objective of this study ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4076

    authors: Subbaramaiah K,Howe LR,Port ER,Brogi E,Fishman J,Liu CH,Hla T,Hudis C,Dannenberg AJ

    更新日期:2006-05-15 00:00:00

  • Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.

    abstract::Mitogen-activated protein kinases function in signal transduction pathways that are involved in controlling key cellular processes in many organisms. A mammalian member of this kinase family, MKK4/JNKK1/SEK1, has been reported to link upstream MEKK1 to downstream stress-activated protein kinase/JNK1 and p38 mitogen-ac...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Teng DH,Perry WL 3rd,Hogan JK,Baumgard M,Bell R,Berry S,Davis T,Frank D,Frye C,Hattier T,Hu R,Jammulapati S,Janecki T,Leavitt A,Mitchell JT,Pero R,Sexton D,Schroeder M,Su PH,Swedlund B,Kyriakis JM,Avruch J,Bar

    更新日期:1997-10-01 00:00:00

  • Induction of centrosome amplification during arsenite-induced mitotic arrest in CGL-2 cells.

    abstract::Arsenite-induced mitotic abnormalities result in mitotic death in several cancer cell lines. However, how arsenite induces these effects is not known. We have previously shown that arsenite induces mitotic arrest, mitotic abnormalities, and mitotic death in CGL-2 cells. To further delineate the mechanism of action of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2308

    authors: Yih LH,Tseng YY,Wu YC,Lee TC

    更新日期:2006-02-15 00:00:00

  • Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

    abstract::The s.c.-propagated murine glioma, GL-26, was established in tissue culture. The tissue culture line, with a doubling time of 36 hr, was used as the common source for all tumor cells. Suspensions of the tumor cells were transplanted intracerebrally in mice to produce an anaplastic ependymoblastoma. In vitro 51-Cr cyto...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Albright L,Madigan JC,Gaston MR,Houchens DP

    更新日期:1975-03-01 00:00:00

  • Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.

    abstract::Sphingosine-1-phosphate is a potent lipid mediator formed by phosphorylation of sphingosine, a metabolite of sphingolipids, catalyzed by two sphingosine kinase (SphK) isoenzymes, SphK1 and SphK2. Expression of SphK2, which is enriched in the nucleus of MCF7 human breast cancer cells, increased expression of the cyclin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2090

    authors: Sankala HM,Hait NC,Paugh SW,Shida D,Lépine S,Elmore LW,Dent P,Milstien S,Spiegel S

    更新日期:2007-11-01 00:00:00

  • Altered amino acid kinetics in rats with progressive tumor growth.

    abstract::The present study was designed to determine whether alterations in host metabolism associated with progressive tumor growth were a result of the anorexia frequently observed with cancer or could be attributed to other direct tumor effects. Rates of tyrosine flux, oxidation, and incorporation into protein, as well as f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kawamura I,Moldawer LL,Keenan RA,Batist G,Bothe A Jr,Bistrian BR,Blackburn GL

    更新日期:1982-03-01 00:00:00

  • An Immune-Inflammation Gene Expression Signature in Prostate Tumors of Smokers.

    abstract::Smokers develop metastatic prostate cancer more frequently than nonsmokers, suggesting that a tobacco-derived factor is driving metastatic progression. To identify smoking-induced alterations in human prostate cancer, we analyzed gene and protein expression patterns in tumors collected from current, past, and never sm...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3630

    authors: Prueitt RL,Wallace TA,Glynn SA,Yi M,Tang W,Luo J,Dorsey TH,Stagliano KE,Gillespie JW,Hudson RS,Terunuma A,Shoe JL,Haines DC,Yfantis HG,Han M,Martin DN,Jordan SV,Borin JF,Naslund MJ,Alexander RB,Stephens RM,Loffr

    更新日期:2016-03-01 00:00:00

  • Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming.

    abstract::The most deadly phase in cancer progression is attributed to the inappropriate acquisition of molecular machinery leading to metastatic transformation and spread of disease to distant organs. Although it is appreciated that metastasis involves epithelial-mesenchymal interplay, the underlying mechanism defining this pr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-3223

    authors: Powell AE,Anderson EC,Davies PS,Silk AD,Pelz C,Impey S,Wong MH

    更新日期:2011-02-15 00:00:00

  • Inhibition of cyclic AMP-triggered aromatase gene expression in human choriocarcinoma cells by antisense oligodeoxynucleotide.

    abstract::Aromatase, an endomembrane-bound cytochrome P450, is the key enzyme of estrogen biosynthesis. Aromatase inhibitors, therefore, are clinically important tools in the treatment of estrogen-dependent tumor growth. To improve the specificity of these tools, inhibition at the nucleic acid level was examined. An antisense o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ackermann K,Fauss J,Pyerin W

    更新日期:1994-09-15 00:00:00

  • Assignment of common allele loss in osteosarcoma to the subregion 17p13.

    abstract::Human osteosarcomas frequently show loss of alleles on chromosome 17 as well as those on chromosome 13 that harbors the retinoblastoma gene, indicating concerted operation of another tumor-suppressing gene on chromosome 17. To assign the affected gene to a defined region of chromosome 17, we performed mitotic recombin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Toguchida J,Ishizaki K,Nakamura Y,Sasaki MS,Ikenaga M,Kato M,Sugimoto M,Kotoura Y,Yamamuro T

    更新日期:1989-11-15 00:00:00

  • Purification and properties of hamster liver ligandins, glutathione S-transferases.

    abstract::Glutathione S-transferases have been purified to homogeneity from Chinese hamster liver. Three enzyme forms were separated and designated Forms I, II, and III in order of their elution from carboxymethylcellulose columns. The forms exhibit close physical similarities to glutathione S-transferases B (ligandin) of rat l...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Smith GJ,Ohl VS,Litwack G

    更新日期:1980-06-01 00:00:00

  • SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.

    abstract::SOX9 is a member of the SOX [Sry-related high-mobility group (HMG) box] family of HMG DNA-binding domain transcription factors and is required for the development and differentiation of multiple cell lineages. This report shows that basal epithelial cells express SOX9 in normal prostate, with no detectable expression ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1672

    authors: Wang H,McKnight NC,Zhang T,Lu ML,Balk SP,Yuan X

    更新日期:2007-01-15 00:00:00

  • Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer.

    abstract::In prostate cancer, traditional treatments such as androgen response manipulation often provide only temporary resolution of disease, with emergence of a more aggressive, androgen-independent tumor following initial therapy. To treat recurrent disease, cell surface proteins that are specifically overexpressed on malig...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1252

    authors: Swift SL,Burns JE,Maitland NJ

    更新日期:2010-01-01 00:00:00

  • Gene transfer into brain parenchyma elicits antitumor effects.

    abstract::Gene therapy strategies for cancer currently aim at targeting gene delivery to the malignant cell. In a mouse model of intracerebral Lewis lung carcinoma (3LL), adenoviral vectors transduce not only 3LL cells but also brain parenchymal cells including endothelial cells, neurons, microglia, and astrocytes in vivo. Furt...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fathallah-Shaykh HM,Kafrouni AI,Zhao LJ,Smith GM,Forman J

    更新日期:2000-04-01 00:00:00

  • Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.

    abstract::Fas (CD95/APO-1) is an important mediator of apoptosis. We show that Fas-resistant MCF-7, MDA-MB-231, and MDA-MB-435 human breast cancer cells become responsive to anti-Fas (CD95) agonistic antibody-triggered apoptosis after pretreatment or cotreatment with vitamin E succinate (VES; RRR-alpha-tocopheryl succinate). In...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yu W,Israel K,Liao QY,Aldaz CM,Sanders BG,Kline K

    更新日期:1999-02-15 00:00:00

  • Effect of quinacrine on nuclear structure and RNA synthesis in cultured rat hepatocytes.

    abstract::The effects of quinacrine, an antimetabolite which intercalates into DNA, on the ultrastructure of interphase nuclei and on RNA turnover were studied in primary cultures of rat hepatocytes. Procedures included ultrastructural cytochemical staining for ribonucleoprotein and DNA, autoradiography, and measurement of labe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Leduc EH,Bernhard W,Viron A,Fain J,Puvion E

    更新日期:1981-07-01 00:00:00

  • Characterization and assay of progesterone receptor in human mammary carcinoma.

    abstract::[3H]Pregn-4-ene-3,20-dione ([3H]progesterone)-receptor complexes from human mammary carcinoma were found to be stabilized in the presence of glycerol. The dissociation rate constant was lowered and the equilibrium dissociation constant was decreased (KD=3 nM in the absence of glycerol and 1.1 nM in the presence of 30%...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pichon MF,Milgrom E

    更新日期:1977-02-01 00:00:00

  • Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia.

    abstract::Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and constitutes 15% of adult leukemias. Although overall prognosis for pediatric ALL is favorable, high-risk pediatric patients and most adult patients have significantly worse outcomes. Multiagent chemotherapy is standard of care for both pedi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2238

    authors: Chao MP,Alizadeh AA,Tang C,Jan M,Weissman-Tsukamoto R,Zhao F,Park CY,Weissman IL,Majeti R

    更新日期:2011-02-15 00:00:00

  • In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes.

    abstract::In vivo tumor inhibitory activity of polymorphonuclear leukocytes (PMN) treated in vitro with lymphokine(s) (LK) was investigated with Winn's assay. Culture supernatants of BALB/c mouse spleen cells incubated with a streptococcal preparation, OK-432, were used as an LK source. With the use of a [3H]uridine release ass...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fujii Y,Kimura S,Arai S,Sendo F

    更新日期:1987-11-15 00:00:00

  • Antiproliferative effects of enediynes on AIDS-derived Kaposi's sarcoma cells.

    abstract::We have investigated the antiproliferative and cytotoxic effects of selected enediynes against three Kaposi's sarcoma (KS) cell lines. The enediynes tested were found to be very potent in inhibiting the growth of KS cells. Treatment with concentrations of 10(-10) M or less were capable of producing 50% inhibition of g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Corbeil J,Richman DD,Wrasidlo W,Nicolaou KC,Looney DJ

    更新日期:1994-08-15 00:00:00

  • ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates.

    abstract::ABCG2 is an ATP-binding cassette transporter that confers resistance to various chemotherapeutic agents. Recent studies have established that an Arg (wild-type) to Gly mutation at amino acid 482 in ABCG2 alters substrate specificity. Here, we explored the role of this G482 mutation in antifolate resistance using a cli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-4547

    authors: Shafran A,Ifergan I,Bram E,Jansen G,Kathmann I,Peters GJ,Robey RW,Bates SE,Assaraf YG

    更新日期:2005-09-15 00:00:00

  • Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.

    abstract::We have recently reported that cultured human monocytes are susceptible to lysis by autologous lymphokine-activated killer (LAK) cells. In an attempt to modulate the sensitivity of monocytes to LAK-mediated lysis, monocytes were cultured in the presence of recombinant human granulocyte-macrophage colony-stimulating fa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blanchard DK,Serbousek D,Djeu JY

    更新日期:1989-09-15 00:00:00

  • Exploiting DNA Replication Stress for Cancer Treatment.

    abstract::Complete and accurate DNA replication is fundamental to cellular proliferation and genome stability. Obstacles that delay, prevent, or terminate DNA replication cause the phenomena termed DNA replication stress. Cancer cells exhibit chronic replication stress due to the loss of proteins that protect or repair stressed...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-3631

    authors: Ubhi T,Brown GW

    更新日期:2019-04-15 00:00:00

  • Preparation of synthetic polypeptide domains of carcinoembryonic antigen and their use in epitope mapping.

    abstract::Genes encoding the four principal polypeptide domains (N, A1-B1, A2-B2, and A3-B3) of carcinoembryonic antigen (CEA) were synthesized and expressed in Escherichia coli as fusion products with bacterial CMP-KDO synthetase (CKS). The four synthetic fusion proteins were purified in high yield and used as targets in Weste...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hass GM,Bolling TJ,Kinders RJ,Henslee JG,Mandecki W,Dorwin SA,Shively JE

    更新日期:1991-04-01 00:00:00

  • Correlation of amino acid fucoside labeling patterns with tumorigenicity of mouse mammary epithelial cells.

    abstract::The amino acid fucosides of tumorigenic and nontumorigenic mouse mammary gland-derived cells were studied. The cells examined included tumorigenic cell lines derived from mammary carcinomas of the following etiologies: induction by hormone; virus; and chemical carcinogen. Also studied were cells derived from normal ma...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Steiner MR,Richards CS,Butel JS,Medina D

    更新日期:1983-06-01 00:00:00

  • Monoclonal antibodies to an ectopically expressed alkaline phosphatase in a human malignant cell line.

    abstract::The D98/AH-2 cell line (a subline of HeLa) expresses a form of alkaline phosphatase (ALP) which closely resembles the adult and fetal intestinal forms of ALP. To characterize this ectopic form of ALP, four monoclonal antibodies were raised against D98/AH-2 ALP, and their binding with ALPs from D98/AH-2 cells, placenta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wray LK,Harris H

    更新日期:1983-02-01 00:00:00